biomedicina slovenica


"Sarcoma, experimental" : 101

  1. Serša Gregor; Sedlar Aleš; Kranjc Simona; Čemažar Maja
    Radiosensitizing effect of intratumoral mIL-12 electrogene therapy on murine sarcoma
    2010
  2. Sedlar Aleš; Kranjc Simona; Čemažar Maja; Serša Gregor
    Radiosensitizing effect of intratumoral mIL-12 electrogene therapy in murine sarcoma
    2011
  3. Serša Gregor; Sedlar Aleš; Kranjc Simona; Čemažar Maja
    Radiosensitizing effect of intratumoral mIL-12 electrogene therapy in murine sarcoma
    2011
  4. Serša G; Kranjc S; Scancar J; Kržan M; Čemažar M
    Electrochemotherapy of mouse sarcoma tumors using electric pulse trains with repetition frequencies of 1 Hz and 5 kHz
    2010
  5. Panter Gabriela; Oblak Alja; Kranjc Simona; Čemažar Maja; Serša Gregor; Jerala Roman
    Cancer immunotherapy by constitutively active Toll-like receptor 4
    2010
  6. Sedlar Aleš; Kranjc Simona; Čemažar Maja; Serša Gregor
    Radiosensitizing effect of intratumoural mIL-12 electrogene therapy on murine sarcoma
    2010
  7. Serša Gregor
    Electroporation in electrochemotherapy of tumors
    2009
  8. Pavlin Darja; Čemažar Maja; Kamenšek Urška; Tozon Nataša; Pogačnik Azra; Serša Gregor
    Local and systemic antitumor effect of intratumoral and peritumoral IL-12 electrogene therapy on murine sarcoma
    2009
  9. Tevž Gregor; Kranjc Simona; Čemažar Maja; Kamenšek Urška; Cör Andrej; Kržan Mojca; Vidic Suzana; Pavlin Darja; Serša Gregor
    Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas
    2009
  10. Čemažar Maja; Golzio Muriel; Serša Gregor; Hojman Pernille; Kranjc Simona; Vidic Suzana; Rols Marie-Pierre; Teissie Justin
    Control by pulse parameters of DNA electrotransfer into solid tumors in mice
    2009
  11. Čemažar Maja; Kranjc Simona; Grošel Alenka; Šentjurc Marjeta; Serša Gregor
    Increased radiosensitization of bleomycin and cisplatin by electroporation of cells and tumors in mice
    2005
  12. Grošel Alenka; Serša Gregor; Kranjc Simona; Čemažar Maja
    Electrogene therapy with p53 of murine sarcomas alone or combined with electrochemotherapy using cisplatin
    2006
  13. Coer A; Legan M; Štiblar-Martinčič D; Čemažar M; Serša G
    Comparison of two hypoxic markers: pimonidazole and glucose transporter 1 (Glut-1)
    2007
  14. Mesojednik S; Pavlin D; Serša G; Coer A; Kranjc S; Grosel A; Tevž G; Čemažar M
    Tumor electrotransfection progress and prospects: the impact of knowledge about tumor histology
    2007
  15. Mesojednik S; Pavlin D; Grošel A; Kranjc S; Čemažar M
    Electrically-assisted gene delivery to tumors in mice is time dependent
    2005
  16. Grošel Alenka
    Vpliv kombinacije elektrogenske terapije S p53 in elektrokemoterapije s cisplatinom na humane karcinomske celične linije in mišje sarkome
    2005
  17. Kranjc Simona; Čemažar Maja; Grošel Alenka; Šentjurc Marjeta; Serša Gregor
    Radiosensitising effect of electrochemotherapy with bleomycin in LPB sarcoma cells amd tumors in mice
    2005
  18. Fonda Irena
    Spreminjanje biološke aktivnosti dejavnika tumorske nekroze alfa (TNF-alfa) in njegovih analogov
    [Changing biological activity of tumour necrosis factor alpha (TNF-alpha) and its analogues]
    2005
  19. Kranjc S; Čemažar M; Grošel A; Serša G
    Increased radiosensitizing effect of bleomycin or cisplatin on LPB sarcoma tumor cells and tumors with localy drug delivery method, electroporation
    2004
  20. Karner Katarina Barbara; Lešničar Hotimir; Čemažar Maja; Serša Gregor
    Antitumor effectiveness of hyperthermia is potentiated by local application of electric pulses to LPB tumours in mice
    2004
  21. Kranjc Simona
    Vpliv elektroporacije na radiosenzibilizirajoči učinek bleomicina in cisplatina pri sarkomskih celicah in tumorjih LPB
    2003
  22. Jarm Tomaž; Podobnik Blaž; Serša Gregor; Miklavčič Damijan
    Effect of hydralazine on blood flow, oxygenation, and interstitial fluid pressure in subcutaneous tumors
    2003
  23. Jarm Tomaž; Čemažar Maja; Steinberg Fritz; Streffer Christian; Serša Gregor; Miklavčič Damijan
    Perturbation of blood flow as a mechanism of anti-tumour action of direct current electrotherapy
    2003
  24. Kranjc Simona; Čemažar Maja; Grošel Alenka; Ščančar Janez; Serša Gregor
    Electroporation of LPB sarcoma cells in vitro and tumors in vivo increases the radiosensitizing effect of cisplatin
    2003
  25. Mekid H; Tounekti O; Spatz A; Čemažar M; El-Kebir FZ; Mir LM
    In vivo evolution of tumour cells after the generation of double-strand DNA breaks
    2003
  26. Serša G; Kržič M; Šentjurc M; Ivanuša T; Beravs K; Kotnik V; Coer A; Swartz HM; Čemažar M
    Reduced blood flow and oxygenation in SA-I tumours after electrochemotherapy with cisplatin
    2002
  27. Miklavčič D; Pucihar G; Mir LM; Puc M; Flisar K; Maček-Lebar A; Mali M; Serša G; Kranjc S; Čemažar M; Petkovšek M; Nastran J
    Increased pulse repetition frequency for effective and less painful electrochemotherapy
    2003
  28. Serša Gregor; Čemažar Maja; Miklavčič Damijan
    Tumor blood flow modifying effects of electrochemotherapy: a potential vascular targeted mechanism
    [Učinki elektrokemoterapije na pretok krvi v tumorjih in njeni možni mehanizmi delovanja ciljani na žilje tumorja]
    2003
  29. Jarm Tomaž; Serša Gregor; Miklavčič Damijan
    Is the luminescence-based optical method suitable for prolonged monitoring of tumour oxygenation?
    2002
  30. Malovrh Tadej; Serša Gregor; Kotnik Vladimir; Škoberne Mojca; Čemažar Maja
    Preparation and analysis of cells from different tissues in cancer research
    2002
  31. Kranjc Simona; Čemažar Maja; Grošel Alenka; Ščančar Janez; Serša Gregor
    Radiosensitization of LPB fibrosarcoma mouse tumor model by electroporation with cisplatin, in vitro and in vivo
    2002
  32. Lacković I; Magjarević R; Kovačič D; Serša G; Miklavčič D
    Assessment of tumor tissue electroporation in vivo using electrical impedance
    2002
  33. Maček-Lebar Alenka; Serša Gregor; Kranjc Simona; Grošelj Alenka; Miklavčič Damijan
    Optimisation of pulse parameters in vitro for in vivo electrochemotherapy
    2002
  34. Čemažar Maja; Parkins Charles S; Holder Angela L; Kranjc Simona; Chaplin David J; Serša Gregor
    Cytotoxicity of bioreductive drug tirapazamine is increased by application of electric pulses in SA-1 tumours in mice
    2001
  35. Čemažar M; Miklavčič D; Mir LM; Belehradek J-Jr; Bonnay M; Fourcault D; Serša G
    Electrochemotherapy of tumours resistant to cisplatin: a study in a murine tumour model
    2001
  36. Jarm Tomaž; Lešničar Hotimir; Serša Gregor; Miklavčič Damijan
    First experience with a novel luminescence-based optical sensor for measurement of oxygenation in tumors
    [Prve izkušnje z novo luminiscenčno optično metodo za merjenje oksigenacije v tumorjih]
    2001
  37. Beravs K; Ivanuša T; Serša G; Čemažar M; Jevtič V; Demšar F
    MRI macromolecular contrast agents as indicators of tumor starvation
    2000
  38. Karner Katarina Barbara
    Učinek električnih impulzov in pregrevanja na krvni pretok in rast mišjega tumorja in vivo
    2001
  39. Ivanuša T
    Blood flow evaluation in SA-1 tumours in mice using macromolecular contrast agents in magnetic resonance imaging
    [Merjenje pretoka krvi v SA-1 tumorjih miši z uporabo makromolekularnih kontrastnih sredstev pri slikanju z magnetno resonanco]
    2001
  40. Ivanuša Teodora; Beravs Katarina; Čemažar Maja; Jevtič Vladimir; Demšar Franci; Serša Gregor
    MRI macromolecular contrast agents as indicators of changed tumor blood flow
    [Uporaba kontrastno povdarjenega dinamičnega MR slikanja za spremljanje pretoka krvi v tumorjih]
    2001
  41. Serša Gregor; Kržič Mateja; Šentjurc Marjeta; Ivanuša Teodora; Beravs Katarina; Čemažar Maja; Auersperg Marija; Swartz Harold M
    Reduced tumor oxygenation by treatment with vinblastine
    2001
  42. Beravs K; Ivanuša T; Demšar F; Jevtić V; Serša I; Serša G
    Novel macromolecular contrast agents for dynamic contrast enhanced MRI
    2000
  43. Jarm Tomaž; Steinberg Fritz; Čemažar Maja; Streffer Christian; Serša Gregor; Miklavčič Damijan
    Correlation between results of different methods for measurement of blood perfusion and oxygenation changes in tumors after electrotherapy
    2000
  44. Ivanuša T; Beravs K; Demšar F; Jevtić V; Serša G
    Electric pulses induced changes in tumor blood flow: dynamic contrast-enhanced MRI study
    2000
  45. Serša Gregor; Čemažar Maja
    Tumor blood flow modifying and anti-vascular effect of electrochemotherapy
    2000
  46. Jarm T; Wickramasinghe YABD; Deakin M; Čemažar M; Elder J; Rolfe P; Serša G; Miklavčič D
    Blood perfusion of subcutaneous tumours in mice following the application of low-level direct electric current
    1999
  47. Serša Gregor; Čemažar Maja; Miklavčič Damijan; Chaplin David J
    Tumor blood flow modifying effect of electrochemotherapy with bleomycin
    1999
  48. Podobnik Blaž; Miklavčič Damijan
    Influence of hydralazine on interstitial fluid pressure in experimental tumors - a preliminary study
    [Vpliv hydralazina na tlak medcelične tekočine v poskusnih tumorjih]
    2000
  49. Čemažar Maja; Auersperg Marija; Serša Gregor
    Antitumor effectiveness of bleomycin on SA-1 tumor after pretreatment with vinblastine
    [Protitumorsko delovanje bleomicina na SA-1 tumorjih po predhodni terapiji z vinblastinom]
    2000
  50. Serša G; Čemažar M; Parkins CS; Chaplin DJ
    Tumour blood flow changes induced by application of electric pulses
    1999
  51. Čemažar Maja; Marolt Darja; Lavrič Mira; Serša Gregor
    Comparison of colorimetric MTT and clonogenic assays for irradiation and cisplatin treatment on murine fibrosarcoma SA-1 cells
    [Primerjava kolorimetričnega testa MTT in testa klonogenosti na mišjih fibrosarkomskih SA-1 celicah po obsevanju in zdravljenju s cisplatinom]
    1999
  52. Fras AP; Kranjc Simona; Čemažar Maja; Serša Gregor
    Cryosurgery combined with radiotherapy of tumors in mice
    [Kriokirurgija mišjih tumorjev SA-1 v kombinaciji z obsevanjem]
    1999
  53. Čemažar M; Miklavčič D; Ščančar J; Dolžan V; Golouh R; Serša G
    Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin
    1999
  54. Čemažar Maja
    Predictive assays of tumor response to chemo and radiotherapy
    [Napovedni testi za izid zdravljenja tumorjev po kemo in radioterapiji]
    1999
  55. Miklavčič Damijan; Beravs Katarina; Šemrov Dejan; Čemažar Maja; Demšar Franci; Serša Gregor
    The importance of electric field distribution for effective in vivo electroporation of tissues
    1998
  56. Jarm T; Čemažar M; Serša G; Miklavčič D
    Blood perfusion in a murine fibrosarcoma tumor model after direct current electrotherapy: a study with 86Rb extraction technique
    1998
  57. Serša Gregor; Beravs Katarina; Čemažar Maja; Miklavčič Damijan; Demšar Franci
    Contrast enhanced MRI assessment of tumor blood volume after application of electric pulses
    1998
  58. Novaković Srdjan; Jezeršek Barbara
    Simple but extremely effective autologous tumor vaccines
    [Enostavne avtologne tumorske vakcine]
    1998
  59. Kragelj Rudi; Šemrov Dejan; Karba Rihard; Čemažar Maja; Serša Gregor; Miklavčič Damijan
    Korelacija med učinkovitostjo elektrokemoterapije in električnim poljem v poskusnem tumorskem modelu
    [Correlation between effectiveness of electrochemotherapy and electric field in experimental tumor model]
    1998
  60. Čemažar Maja; Miklavčič Damijan; Serša Gregor
    Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy
    1998
  61. Čemažar Maja; Auersperg Marija; Serša Gregor
    Vinblastine increases antitumor effectiveness of bleomycin
    [Viblastin poveča protitumorsko učinkovitost bleomicina]
    1997
  62. Novaković S; Menart V; Gaberc-Porekar V; Štalc A; Serša G; Čemažar M; Jezeršek B
    New TNF-alfa analogues: a powerful but less toxic biological tool against tumours
    1997
  63. Kitak Nataša; Miklavčič Damijan; Serša Gregor
    Protitumorski učinki elektroterapije v kombinaciji z modifikatorji biološkega odziva
    [Anti-tumor effects of electrotherapy combined with biological response modifieres]
    1997
  64. Miklavčič Damijan; An Dongjian; Belehradek Jean Jr; Mir Lluis M
    Host's immune response in electrotherapy of murine tumors by direct current
    1997
  65. Miklavčič D; Jarm T; Čemažar M; Serša G; An DJ; Belehradek J Jr; Mir LM
    Tumor treatment by direct electric current. Tumor perfusion changes
    1997
  66. Serša Gregor; Miklavčič Damijan; Čemažar Maja; Belehradek Jean Jr; Jarm Tomaž; Mir Lluis M
    Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocompetent and immunodeficient mice
    1997
  67. Čemažar M; Milačič R; Miklavčič D; Serša G
    Evidence of increased platinum concentration in the SA-1 tumors after electrochemotherapy with cisplatin
    1997
  68. Pušenjak J; Miklavčič D; Serša G
    Tumor temperature after application of electric pulses
    1997
  69. Miklavčič D; Jarm T; Čemažar M; Serša G
    Electric direct current in tumor treatment
    1997
  70. Novaković S; Menart V; Gaberc-Porekar V; Jezeršek B
    TNF-alpha analogues: a possible way to broaden the therapeutic margin of TNF-alpha
    1996
  71. Novaković Srdan; Menart Viktor; Gaberc-Porekar Vlatka; Štalc Anton; Serša Gregor; Čemažar Maja
    Antitumor activity of the analogues of rHuTNF-alpha
    1996
  72. Cerar A; Pokorn D
    Inhibition of MNNG-induced gastroduodenal carcinoma in rats by synchronous application of wine or 11% ethanol
    1996
  73. Menart V; Kus B; Novaković S; Serša G; Gaberc-Porekar V; Harb V; Miličić S; Štalc A
    Searching for new TNF-alpha analogs having potential application in cancer therapy
    1996
  74. Jarm T; Wickramasinghe YABD; Deakin M; Čemažar M; Miklavčič D; Serša G; Elder J; Rolfe P; Vodovnik L
    Blood perfusion and oxygenation of tumours following electrotherapy - A study by means of near infrared spectroscopy and patent blue staining
    1996
  75. Serša G; Miklavčič D; Čemažar M; Belehradek J Jr; Mir LM
    Electrochemotherapy with cisplatin: comparison of anti-tumor effects in immunocompetent and immunodeficient mice
    1996
  76. Kotnik V; Čemažar M; Miklavčič D; Kotnik A; Serša G
    Tumor surveillance can be changed with electrochemotherapy
    1996
  77. Čemažar M; Menart V; Gaberc-Porekar V; Miklavčič D; Serša G
    Potentiation of anti-tumor effectiveness of electrochemotherapy by TNF-alpha on SA-1 tumors in mice
    1996
  78. Cerar A; Matjašič M; Kališnik M; Stare J
    Effect of multiple applications of Newcastle disease virus on the inhibition of Ehrlich ascites tumor
    [Učinek večkratnih aplikacij virusa Newcastleske bolezni na zaviralno rast Ehrlichovega ascitesnega tumorja]
    1995
  79. Serša G; Čemažar M; Miklavčič D; Mir LM
    Electrochemotherapy: variable anti-tumor effect on different tumor models
    1994
  80. Miklavčič D; Tratar R; Karba R; Jarm T; Čemažar M; Serša G; Vodovnik L
    Matematični model elektrokemoterapije s cisplatinom
    [Mathematical model of electrochemotherapy by cisplatinum]
    1994
  81. Miklavčič D; Fajgelj A; Serša G
    Tumour treatment by direct electric current: electrode material deposition
    1994
  82. Serša G; Miklavčič D
    Combined treatment of murine SA-1 tumors by human leukocyte interferon alpha and electrotherapy
    1993
  83. Serša G; Golouh R; Miklavčič D
    Anti-tumor effect of tumor necrosis factor combined with electrotherapy on mouse sarcoma
    1994
  84. Serša G; Čemažar M; Šentjurc M; Us-Krašovec M; Kalebić S; Drašlar K; Auersperg M
    Effects of vinblastine on cell membrane fluidity and the growth of SA-1 tumor in mice
    1994
  85. Novaković Srdjan
    Vpliv analogov TNF in MDP na maligne tumorje poskusnih živali
    1994
  86. Miklavčič D; Serša G; Kryžanowski M; Novaković S; Bobanović F; Golouh R; Vodovnik L
    Tumor treatment by direct electric current - tumor temperature and pH, electrode material and configuration
    1993
  87. Bobanović F; Miklavčič D; Serša G; Novaković S; Vodovnik L
    Electrochemical reactions at electrode-tissue interface and their role in tumor growth retardation achieved by electrotherapy
    1992
  88. Miklavčič D; Serša G; Vodovnik L
    Electric direct current in treatment of cancer
    1992
  89. Serša G; Miklavčič D; Batista U; Novaković S; Bobanović F; Vodovnik L
    Anti-tumor effect of electrotherapy alone or in combination with interleukin-2 in mice with sarcoma and melanoma tumors
    1992
  90. Miklavčič D; Vodovnik L; Bobanović F; Reberšek S; Serša G; Novaković S; Golouh R
    Local treatment of murine tumors by electric direct current
    1992
  91. Serša G; Novaković S; Štalc A
    Tumor mass is a critical factor in peritumoral treatment with tumor necrosis factor
    1992
  92. Miklavčič D; Serša G; Vodovnik L
    Direct electric current in treatment of murine solid tumors: electrode material and configurations
    1992
  93. Vodovnik L; Miklavčič D; Serša G
    Modulation of cell cycle by low level direct current in cancer
    1992
  94. Serša G; Novaković S; Štalc A
    Antitumor effect of recombinant human tumor necrosis factor-alpha analog combined with desmuramyl dipeptides LK-409 or LK-410 on sarcoma in mice
    1992
  95. Serša G; Novakovič S; Miklavčič D
    Potentiation of bleomycin antitumor effectiveness by electrotherapy
    1993
  96. Miklavčič D; Reberšek S; Serša G; Novaković S
    Nonthermal antitumor effect of electrical direct current on murine fibrosarcoma SA-1 tumor model
    1991
  97. Miklavčič D; Serša G; Novaković S; Jerčinović A
    Electrical current in treatment of malignant tumors
    1990
  98. Miklavčič D; Serša G; Bobanović F; Novaković S; Reberšek S
    Tumor growth retardation due to exogenous electrical current and/or fields
    1991
  99. Miklavčič D; Serša G; Novaković S; Reberšek S
    Tumor bioelectrical potential and its possible exploitation for tumor growth retardation
    1990
  100. Serša G; Miklavčič D
    Inhibition of SA-1 tumor growth in mice by human lekocyte interferon alpha combined with low-level direct current
    1990

1 101  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics